Chernajovsky Y - Search Results

1

TNF receptor fusion proteins are effective inhibitors of TNF-mediated cytotoxicity on human KYM-1D4 rhabdomyosarcoma cells.

Butler DM, Scallon B, Meager A, Kissonerghis M, Corcoran A, Chernajovsky Y, Feldmann M, Ghrayeb J, Brennan FM. Butler DM, et al. Among authors: chernajovsky y. Cytokine. 1994 Nov;6(6):616-23. doi: 10.1016/1043-4666(94)90049-3. Cytokine. 1994. PMID: 7893970

2

Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.

Neve R, Kissonerghis M, Clark J, Feldmann M, Chernajovsky Y. Neve R, et al. Among authors: chernajovsky y. Cytokine. 1996 May;8(5):365-70. doi: 10.1006/cyto.1996.0050. Cytokine. 1996. PMID: 8726664

3

Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.

Corcoran AE, Scallon BJ, Trinh H, Chernajovsky Y, Ghrayeb J, Feldmann M. Corcoran AE, et al. Among authors: chernajovsky y. Eur Cytokine Netw. 1998 Sep;9(3):255-62. Eur Cytokine Netw. 1998. PMID: 9831174 Free article.

4

Potentiation of TNF-alpha toxicity by conjugation with ricin A-chain.

Gould DJ, Foxwell BM, Feldmann M, Chernajovsky Y. Gould DJ, et al. Among authors: chernajovsky y. Cytokine. 1998 Dec;10(12):931-9. doi: 10.1006/cyto.1998.0395. Cytokine. 1998. PMID: 10049516

5

Synergism of glucocorticoids with granulocyte macrophage colony stimulating factor (GM-CSF) but not interferon gamma (IFN-gamma) or interleukin-4 (IL-4) on induction of HLA class II expression on human monocytes.

Sadeghi R, Hawrylowicz CM, Chernajovsky Y, Feldmann M. Sadeghi R, et al. Among authors: chernajovsky y. Cytokine. 1992 Jul;4(4):287-97. doi: 10.1016/1043-4666(92)90069-4. Cytokine. 1992. PMID: 1515553

6

Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells.

Clarke CJ, Taylor-Fishwick DA, Hales A, Chernajovsky Y, Sugamura K, Feldmann M, Foxwell BM. Clarke CJ, et al. Among authors: chernajovsky y. Eur J Immunol. 1995 Oct;25(10):2961-6. doi: 10.1002/eji.1830251037. Eur J Immunol. 1995. PMID: 7589098

7

Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.

Corcoran AE, Barrett K, Turner M, Brown A, Kissonerghis AM, Gadnell M, Gray PW, Chernajovsky Y, Feldmann M. Corcoran AE, et al. Among authors: chernajovsky y. Eur J Biochem. 1994 Aug 1;223(3):831-40. doi: 10.1111/j.1432-1033.1994.tb19059.x. Eur J Biochem. 1994. PMID: 8055960 Free article.

8

Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor.

Chernajovsky Y, Adams G, Podhajcer OL, Mueller GM, Robbins PD, Feldmann M. Chernajovsky Y, et al. Gene Ther. 1995 Dec;2(10):731-5. Gene Ther. 1995. PMID: 8750012

9

The murine p75 TNF receptor promoter region: DNA sequence and characterization of a cis-acting silencer.

Kissonerghis M, Daly G, Feldmann M, Chernajovsky Y. Kissonerghis M, et al. Among authors: chernajovsky y. Mol Immunol. 1999 Feb;36(2):125-34. doi: 10.1016/s0161-5890(99)00022-x. Mol Immunol. 1999. PMID: 10378684

10

Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives.

Chernajovsky Y, Feldmann M, Maini RN. Chernajovsky Y, et al. Br Med Bull. 1995 Apr;51(2):503-16. doi: 10.1093/oxfordjournals.bmb.a072976. Br Med Bull. 1995. PMID: 7552079 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters